What are the treatment options for non-muscle-invasive and muscle-invasive bladder cancer?

Updated: Feb 23, 2021
  • Author: Kara N Babaian, MD, FACS; Chief Editor: Bradley Fields Schwartz, DO, FACS  more...
  • Print

The treatment of non–muscle-invasive (Ta, T1, carcinoma in situ [CIS]) and muscle-invasive bladder cancer should be differentiated. Treatments within each category include surgical and medical approaches. European Association of Urology (EAU) and National Comprehensive Cancer Network (NCCN) guidelines for non–muscle-invasive cancer strongly recommend stratifying risk of recurrence and progression and using risk tables to determine appropriate treatment. [1, 69]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!